Humanigen Inc - Company Profile

Powered by

All the sales intelligence you need on Humanigen Inc in one solution.

  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Humanigen Inc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Humanigen Inc.

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Humanigen Inc (Humanigen), a subsidiary of Taran Therapeutics Inc, is a clinical-stage biopharmaceutical company that develops of immuno-oncology and immunomodulatory antibodies. The company's pipeline products include ifabotuzumab(anti-EphA3) is for the treatment of solid tumor giloblastoma multiforme (GBM), multiple hematologic malignancies; lenzilumab(anti-GM-CSF) targets chronic myelomonocytic leukemia (CMML), acute graft versus host disease (GVHD), hospitalized covid-19 pneumonia (liver- air), hospitalized covid-19 pneumonia (Activ-5/Bet-B), severe asthama, persistent asthama, chimeric antigen receptor (CAR) treatment-related toxicities, rheumatoid arthritis. Humanigen is headquartered in Burlingame, California, the US.

Gain a 360-degree view of Humanigen Inc and make more informed decisions for your business Gain a 360-degree view of Humanigen Inc and make more informed decisions for your business Learn more
Headquarters United States of America

Address 4th Floor, 830 Morris Turnpike, Short Hills, New Jersey, 07078


Telephone 1 973 2003100

No of Employees 6

Industry Pharmaceuticals and Healthcare

Revenue (2022) $2.5M

   

   

Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Learn more

Humanigen Inc premium industry data and analytics

20+

Clinical Trials

Determine Humanigen Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

20+

Catalyst Calendar

Proactively evaluate Humanigen Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

11+

Pipeline Drugs

Identify which of Humanigen Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

8

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

2

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

Products and Services

Products Brands
Pipeline LENZ
Lenzilumab(anti-GM-CSF): Humaneered
Chronic Myelomonocytic Leukemia (CMML)
XYZ
XYZ
XYZ
Understand Humanigen Inc portfolio and identify potential areas for collaboration Understand Humanigen Inc portfolio and identify potential areas for collaboration Learn more
Image for loader

Competitor Comparison

Key Parameters Humanigen Inc Arrowhead Pharmaceuticals Inc Dicerna Pharmaceuticals Inc HemaCare Corp InVivo Therapeutics Holdings Corp
Headquarters United States of America United States of America United States of America United States of America United States of America
City Short Hills Pasadena Lexington Northridge Cambridge
State/Province New Jersey California Massachusetts California Massachusetts
No. of Employees 6 711 - - 6
Entity Type Private Public Private Private Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Learn more
Executives
Name Position Board Since Age
Cameron Durrant, M.D. Chairman; Chief Executive Officer Executive Board - -
Dale Chappell, M.D. Chief Scientific Officer; Director Executive Board - -
Rainer Boehm, M.D. Director Non Executive Board - -
Ronald Barliant Director Non Executive Board - -
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into Humanigen Inc key executives to enhance your sales strategy Gain insight into Humanigen Inc key executives to enhance your sales strategy Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?